Can Fetuin A Be Utilized in the Evaluation of Elderly Patients with Acute Myocardial Infarction?

Raluca Tomoaia1,2, Ruxandra Ștefana Beyer1, Dumitru Zdrenghea2,3

  • 1Cardiology Department, Heart Institute "N. Stăncioiu", 400001 Cluj-Napoca, Romania.

Life (Basel, Switzerland)
|September 28, 2021
PubMed

Insights

Lower Fetuin-A (FA) levels predict early death and incomplete ST segment resolution (STR) after acute myocardial infarction (AMI) treatment. Measuring FA may improve risk assessment in AMI patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Acute Myocardial Infarction

Background:

  • Lower baseline Fetuin-A (FA) is linked to adverse outcomes post-acute myocardial infarction (AMI).
  • The relationship between FA levels, ST segment resolution (STR), and early mortality in AMI remains understudied.

Purpose of the Study:

  • To investigate the association between Fetuin-A (FA) levels and early mortality.
  • To determine if FA levels correlate with incomplete ST segment resolution (STR) after primary percutaneous coronary intervention (PCI) in AMI patients.

Main Methods:

  • 100 AMI patients were divided into sudden cardiac death (SCD) (n=21) and control (n=79) groups.
  • Fetuin-A (FA), NT-proBNP, and troponin levels were measured and correlated with early mortality.
  • The predictive value of FA for STR was assessed using logistic regression.

Main Results:

  • FA levels were significantly lower in patients experiencing SCD (115 vs. 180 ng/mL).
  • Lower FA levels (below 175 ng/mL) were associated with a higher mortality rate (30%).
  • FA was the only biomarker independently associated with incomplete STR after PCI.

Conclusions:

  • Reduced Fetuin-A (FA) levels indicate increased early mortality risk.
  • FA measurement, alongside NT-proBNP, troponin, and STR, can enhance risk stratification for AMI patients.
Abstract